Method of determining vasoreactivity using inhaled nitric oxide
US11154210B2 · kind B2 · utility
1Cited by
49References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2013 |
| Grant date | Oct 26, 2021 |
| Priority date | — |
| Expiry date | Aug 10, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating pulmonary arterial hypertension in a patient can include determining whether a patient with pulmonary arterial hypertension has an enlarged right ventricle or right ventricular dysfunction, where the patient has previously been administered a prostanoid and weaning the patient off of the prostanoid if the patient does not have an enlarged right ventricle or right ventricular dysfunction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.